Pax Labs Inc. valued at $5 billion
Pax Labs Inc, a San Fransisco-based start-up that produces vaporizers, was recently valued at $5 billion. according to Bloomberg. Discreet, portable and high-tech, Pax vaporizers are a huge success in the United States, as cannabis consumption changes.
Frequently dubbed the 'iPhone of cannabis», the Pax resembles a high-tech USB key. Its discretion makes it an asset of choice for consumers on the move, who can modify its settings (temperature, light...) via a smartphone app.
A controversial cousin
The vape is based on the same operating principle as the Juul, a vaporizer for concentrated nicotine. And with good reason: they were both created by James Monsees and Adam Bowen.
The original company was split into two separate entities last year, Juul Labs and Pax Labs, surely to avoid the Juul controversy rubbing off on Pax, but also because the two products are subject to different regulatory frameworks.
Juul has been the subject of controversy, as it has become widely popular among teenagers. Although e-cigarette consumption is less toxic than traditional cigarettes, the nicotine concentration and fad surrounding vaping are causing addiction problems among teenagers. To combat this «epidemic», the FDA has issued an ultimatum to the producers of the most popular devices to prove that they can keep their product out of the hands of minors. Today, an investigation is underway to determine whether Juul Labs marketed its product for teenage consumption.
Vaporizers are sold empty, without cartridges. The cartridges are sold empty to producers who fill and distribute them (often in the same places as the vaporizer), a way of protecting themselves from consumer use, even though the products are more or less clearly intended for the consumption of concentrates, whether nicotine for the Juul or cannabis for certain versions of the Pax (the Pax 3 and the Pax Era).
The company's latest fund-raising totaled $20 million-a round «deliberately small» according to Pax's new CEO, Bharat Vasan, and reduced to investors already involved in the company. Although legally separate, the two companies also share the same investor base.
-
Cannabis in France4 weeks ago
France Sets July as the Deadline for the Widespread Adoption of Medical Cannabis
-
Cannabis in Europe3 weeks ago
Bosnia and Herzegovina Continues to Roll Out Medical Cannabis Following Its Legalization
-
Cannabis in France2 weeks ago
France Submits the Long-Awaited Decree on the Reimbursement of Medical Cannabis to the Council of State
-
Cannabis in Ireland3 weeks ago
The Irish Parliament recommends decriminalizing all drugs
-
Cannabis in the U.S.3 weeks ago
The DEA Begins Hearings on the Federal Rescheduling of Cannabis
-
Cannabis in Switzerland3 weeks ago
St. Gallen, Switzerland, Launches Its 8th Legal Cannabis Pilot Project
-
Cannabis in France3 weeks ago
Reunion Island: The CBD Cannabis Cup Returns to Jardin Maniron on August 16, 2026
-
Business2 weeks ago
China Invests $10 Million in Medical Cannabis in Lebanon



You must be logged in to post a comment Login